

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.97416415 |
| 2 | nuclear pore organization (GO:0006999) | 4.90788541 |
| 3 | mitotic metaphase plate congression (GO:0007080) | 4.84153693 |
| 4 | actin-myosin filament sliding (GO:0033275) | 4.45900079 |
| 5 | muscle filament sliding (GO:0030049) | 4.45900079 |
| 6 | mitotic chromosome condensation (GO:0007076) | 4.12153183 |
| 7 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.11308506 |
| 8 | protein localization to kinetochore (GO:0034501) | 4.08979248 |
| 9 | mitotic nuclear envelope disassembly (GO:0007077) | 4.08491604 |
| 10 | actin-mediated cell contraction (GO:0070252) | 4.04845303 |
| 11 | metaphase plate congression (GO:0051310) | 4.03544834 |
| 12 | mitotic sister chromatid cohesion (GO:0007064) | 4.01250702 |
| 13 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.00658254 |
| 14 | establishment of chromosome localization (GO:0051303) | 3.98048161 |
| 15 | membrane disassembly (GO:0030397) | 3.96430920 |
| 16 | nuclear envelope disassembly (GO:0051081) | 3.96430920 |
| 17 | regulation of centriole replication (GO:0046599) | 3.85263660 |
| 18 | regulation of helicase activity (GO:0051095) | 3.73489254 |
| 19 | histone H2A monoubiquitination (GO:0035518) | 3.66422127 |
| 20 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.62602679 |
| 21 | pore complex assembly (GO:0046931) | 3.61936591 |
| 22 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.58986155 |
| 23 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.58986155 |
| 24 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.58986155 |
| 25 | regulation of spindle organization (GO:0090224) | 3.56142629 |
| 26 | IMP metabolic process (GO:0046040) | 3.53986166 |
| 27 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.52895509 |
| 28 | sister chromatid segregation (GO:0000819) | 3.49260294 |
| 29 | mitotic sister chromatid segregation (GO:0000070) | 3.47555690 |
| 30 | meiotic chromosome segregation (GO:0045132) | 3.46990447 |
| 31 | IMP biosynthetic process (GO:0006188) | 3.46927780 |
| 32 | pre-miRNA processing (GO:0031054) | 3.45482096 |
| 33 | regulation of sister chromatid cohesion (GO:0007063) | 3.42962451 |
| 34 | regulation of translational termination (GO:0006449) | 3.40638242 |
| 35 | positive regulation of chromosome segregation (GO:0051984) | 3.36100480 |
| 36 | protein localization to chromosome, centromeric region (GO:0071459) | 3.35122747 |
| 37 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.33176574 |
| 38 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.33176574 |
| 39 | regulation of mitotic spindle organization (GO:0060236) | 3.32254073 |
| 40 | DNA unwinding involved in DNA replication (GO:0006268) | 3.27671702 |
| 41 | regulation of centrosome cycle (GO:0046605) | 3.21698019 |
| 42 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.21553702 |
| 43 | cellular response to interferon-alpha (GO:0035457) | 3.13668507 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.07416110 |
| 45 | actin filament-based movement (GO:0030048) | 3.06635661 |
| 46 | protein localization to chromosome (GO:0034502) | 3.03087665 |
| 47 | nuclear envelope organization (GO:0006998) | 3.01060852 |
| 48 | regulation of relaxation of muscle (GO:1901077) | 3.00716604 |
| 49 | regulation of chromosome segregation (GO:0051983) | 2.99417758 |
| 50 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.98110063 |
| 51 | spindle checkpoint (GO:0031577) | 2.97821310 |
| 52 | ventricular cardiac muscle cell development (GO:0055015) | 2.97729282 |
| 53 | chromatin remodeling at centromere (GO:0031055) | 2.96458897 |
| 54 | positive regulation of translational initiation (GO:0045948) | 2.96105128 |
| 55 | chromosome segregation (GO:0007059) | 2.94741962 |
| 56 | cardiac muscle cell development (GO:0055013) | 2.93688990 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 2.93499790 |
| 58 | CENP-A containing nucleosome assembly (GO:0034080) | 2.93345392 |
| 59 | notochord development (GO:0030903) | 2.93117932 |
| 60 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.91914994 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.91342433 |
| 62 | modulation by symbiont of host defense response (GO:0052031) | 2.91342433 |
| 63 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.91342433 |
| 64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.91342433 |
| 65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.91342433 |
| 66 | modulation by symbiont of host immune response (GO:0052553) | 2.91342433 |
| 67 | sarcomere organization (GO:0045214) | 2.90322242 |
| 68 | skeletal muscle contraction (GO:0003009) | 2.90203255 |
| 69 | regulation of RIG-I signaling pathway (GO:0039535) | 2.89395108 |
| 70 | corticosteroid receptor signaling pathway (GO:0031958) | 2.88628188 |
| 71 | establishment of integrated proviral latency (GO:0075713) | 2.88284319 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.87855801 |
| 73 | negative regulation of histone methylation (GO:0031061) | 2.82540783 |
| 74 | histone H2A ubiquitination (GO:0033522) | 2.81960238 |
| 75 | response to muscle activity (GO:0014850) | 2.80756743 |
| 76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.80665736 |
| 77 | regulation of RNA export from nucleus (GO:0046831) | 2.79632506 |
| 78 | ribosome assembly (GO:0042255) | 2.79448715 |
| 79 | heterochromatin organization (GO:0070828) | 2.79138195 |
| 80 | regulation of skeletal muscle contraction (GO:0014819) | 2.79125028 |
| 81 | skeletal muscle adaptation (GO:0043501) | 2.78702425 |
| 82 | cardiac cell development (GO:0055006) | 2.76923457 |
| 83 | paraxial mesoderm development (GO:0048339) | 2.76559937 |
| 84 | regulation of sister chromatid segregation (GO:0033045) | 2.76356042 |
| 85 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.76356042 |
| 86 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.76356042 |
| 87 | mitotic spindle checkpoint (GO:0071174) | 2.76157373 |
| 88 | spindle assembly checkpoint (GO:0071173) | 2.75798346 |
| 89 | mitotic spindle assembly checkpoint (GO:0007094) | 2.74498473 |
| 90 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.73559130 |
| 91 | negative regulation of sister chromatid segregation (GO:0033046) | 2.73559130 |
| 92 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.73559130 |
| 93 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.73559130 |
| 94 | negative regulation of chromosome segregation (GO:0051985) | 2.73172572 |
| 95 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.72599079 |
| 96 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.72075095 |
| 97 | natural killer cell mediated immunity (GO:0002228) | 2.72075095 |
| 98 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.72030056 |
| 99 | regulation of centrosome duplication (GO:0010824) | 2.71864538 |
| 100 | postreplication repair (GO:0006301) | 2.70486197 |
| 101 | DNA replication initiation (GO:0006270) | 2.70068855 |
| 102 | kinetochore organization (GO:0051383) | 2.69791237 |
| 103 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.69408865 |
| 104 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.66264067 |
| 105 | protein K6-linked ubiquitination (GO:0085020) | 2.66216651 |
| 106 | sister chromatid cohesion (GO:0007062) | 2.65328454 |
| 107 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.65183928 |
| 108 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.62642043 |
| 109 | negative regulation by host of viral transcription (GO:0043922) | 2.62214426 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61942935 |
| 111 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.61800377 |
| 112 | DNA replication-independent nucleosome organization (GO:0034724) | 2.61800377 |
| 113 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.61739819 |
| 114 | histone exchange (GO:0043486) | 2.61297685 |
| 115 | cullin deneddylation (GO:0010388) | 2.61109305 |
| 116 | regulation of cofactor metabolic process (GO:0051193) | 2.61039820 |
| 117 | regulation of coenzyme metabolic process (GO:0051196) | 2.61039820 |
| 118 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.60048334 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.57032146 |
| 120 | mismatch repair (GO:0006298) | 2.56061680 |
| 121 | DNA geometric change (GO:0032392) | 2.55987437 |
| 122 | peptidyl-arginine N-methylation (GO:0035246) | 2.55820731 |
| 123 | peptidyl-arginine methylation (GO:0018216) | 2.55820731 |
| 124 | myofibril assembly (GO:0030239) | 2.54705883 |
| 125 | DNA duplex unwinding (GO:0032508) | 2.54584195 |
| 126 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.54500933 |
| 127 | regulation of sarcomere organization (GO:0060297) | 2.51185074 |
| 128 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47535993 |
| 129 | microtubule depolymerization (GO:0007019) | 2.46246434 |
| 130 | DNA damage response, detection of DNA damage (GO:0042769) | 2.45297639 |
| 131 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.44654035 |
| 132 | mitotic spindle organization (GO:0007052) | 2.42288470 |
| 133 | skeletal muscle fiber development (GO:0048741) | 2.39877689 |
| 134 | cardiac myofibril assembly (GO:0055003) | 2.39473906 |
| 135 | regulation of DNA endoreduplication (GO:0032875) | 2.33949757 |
| 136 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.33066010 |
| 137 | otic vesicle formation (GO:0030916) | 2.32536021 |
| 138 | striated muscle cell development (GO:0055002) | 2.31915215 |
| 139 | mitotic G2/M transition checkpoint (GO:0044818) | 2.29655952 |
| 140 | negative regulation of DNA recombination (GO:0045910) | 2.29330036 |
| 141 | regulation of cell communication by electrical coupling (GO:0010649) | 2.28760432 |
| 142 | microtubule anchoring (GO:0034453) | 2.28587648 |
| 143 | myotube cell development (GO:0014904) | 2.27487051 |
| 144 | muscle fiber development (GO:0048747) | 2.26549491 |
| 145 | striated muscle contraction (GO:0006941) | 2.25343887 |
| 146 | DNA double-strand break processing (GO:0000729) | 2.25293769 |
| 147 | actomyosin structure organization (GO:0031032) | 2.23293605 |
| 148 | cellular protein complex localization (GO:0034629) | 2.21842926 |
| 149 | negative regulation of microtubule depolymerization (GO:0007026) | 2.21814259 |
| 150 | acrosome assembly (GO:0001675) | 2.20827757 |
| 151 | cholesterol biosynthetic process (GO:0006695) | 2.20572025 |
| 152 | regulation of microtubule depolymerization (GO:0031114) | 2.18940990 |
| 153 | aspartate family amino acid catabolic process (GO:0009068) | 2.16551866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.71962373 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.40616890 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.14262562 |
| 4 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.36518430 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.19361200 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.10762563 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.05165934 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.92695883 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86958556 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.54381245 |
| 11 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.53697715 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.48801774 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14568112 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14271684 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.09053218 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.08545163 |
| 17 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04397907 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02637959 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 10.6619689 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97966573 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97676434 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97093279 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96395717 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92507397 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89581851 |
| 26 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.89509488 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.87046254 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86161189 |
| 29 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.84696866 |
| 30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84313530 |
| 31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76491475 |
| 32 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.71640617 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68480130 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.67401297 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66743317 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.65467494 |
| 37 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62041361 |
| 38 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.59792621 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57225993 |
| 40 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52982847 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46080287 |
| 42 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45795899 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.45326910 |
| 44 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44524880 |
| 45 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.38454223 |
| 46 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.38428883 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37802692 |
| 48 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37109839 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33611012 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33301503 |
| 51 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.32929670 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32078045 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31990152 |
| 54 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.31895360 |
| 55 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30112742 |
| 56 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29726520 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28840331 |
| 58 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28734384 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27375998 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26872828 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26600710 |
| 62 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25855365 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25652155 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24588142 |
| 65 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24040181 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.23641422 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23514372 |
| 68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.23425727 |
| 69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23380121 |
| 70 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22393898 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22345590 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21848834 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20847265 |
| 74 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.19310916 |
| 75 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19155284 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18123137 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18123137 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17645241 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16748174 |
| 80 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.16673442 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16515093 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16068144 |
| 83 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15671310 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15595395 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.14989361 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14056942 |
| 87 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14025978 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10968847 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10931967 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10031535 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09785244 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09500659 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08459866 |
| 94 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.08398428 |
| 95 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08311733 |
| 96 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07298876 |
| 97 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06911367 |
| 98 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06262484 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05810634 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05628670 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05181882 |
| 102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05065691 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04781951 |
| 104 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02843022 |
| 105 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02711983 |
| 106 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01849072 |
| 107 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01456357 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01040164 |
| 109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00918351 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00841942 |
| 111 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00546643 |
| 112 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00374753 |
| 113 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00312953 |
| 114 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99821385 |
| 115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98027293 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97140705 |
| 117 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96086391 |
| 118 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95872665 |
| 119 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95361831 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95360430 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95331646 |
| 122 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.95123914 |
| 123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94942366 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94828196 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94823391 |
| 126 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.94780084 |
| 127 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.93553553 |
| 128 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93346195 |
| 129 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92959036 |
| 130 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92436405 |
| 131 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92381701 |
| 132 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91870142 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91826487 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91826487 |
| 135 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91499586 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90656700 |
| 137 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90656700 |
| 138 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90514581 |
| 139 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.89480470 |
| 140 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.88349840 |
| 141 | EWS_26573619_Chip-Seq_HEK293_Human | 0.86260202 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86206732 |
| 143 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85595344 |
| 144 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.83355673 |
| 145 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.81685469 |
| 146 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.80910551 |
| 147 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80228897 |
| 148 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78521849 |
| 149 | ATF3_27146783_Chip-Seq_COLON_Human | 0.77735952 |
| 150 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.77116692 |
| 151 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.75981416 |
| 152 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75856650 |
| 153 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.74420425 |
| 154 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.73655445 |
| 155 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.72392596 |
| 156 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72357068 |
| 157 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72222346 |
| 158 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.72020221 |
| 159 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.71327820 |
| 160 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71238475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.38653794 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.32802326 |
| 3 | MP0008057_abnormal_DNA_replication | 3.30783156 |
| 4 | MP0005076_abnormal_cell_differentiation | 3.06941604 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.05824404 |
| 6 | MP0010307_abnormal_tumor_latency | 3.04535360 |
| 7 | MP0000751_myopathy | 3.02453793 |
| 8 | MP0003646_muscle_fatigue | 2.99726200 |
| 9 | MP0003077_abnormal_cell_cycle | 2.97666691 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.94322289 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.82461186 |
| 12 | MP0003123_paternal_imprinting | 2.62696739 |
| 13 | MP0003941_abnormal_skin_development | 2.32396134 |
| 14 | MP0000350_abnormal_cell_proliferation | 2.27958893 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.14248865 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.11287000 |
| 17 | MP0001730_embryonic_growth_arrest | 2.09229140 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.06821679 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.99167353 |
| 20 | MP0003890_abnormal_embryonic-extraembry | 1.99129889 |
| 21 | MP0010030_abnormal_orbit_morphology | 1.98277838 |
| 22 | MP0009697_abnormal_copulation | 1.92971764 |
| 23 | MP0008058_abnormal_DNA_repair | 1.87663573 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.87026968 |
| 25 | MP0001299_abnormal_eye_distance/ | 1.86036208 |
| 26 | MP0003950_abnormal_plasma_membrane | 1.82036833 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.76232923 |
| 28 | MP0003136_yellow_coat_color | 1.74417685 |
| 29 | MP0003303_peritoneal_inflammation | 1.69822775 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.68662716 |
| 31 | MP0008932_abnormal_embryonic_tissue | 1.68324322 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.64054395 |
| 33 | MP0001697_abnormal_embryo_size | 1.63353673 |
| 34 | MP0001348_abnormal_lacrimal_gland | 1.56947101 |
| 35 | MP0005380_embryogenesis_phenotype | 1.56646040 |
| 36 | MP0001672_abnormal_embryogenesis/_devel | 1.56646040 |
| 37 | MP0005620_abnormal_muscle_contractility | 1.56413661 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.55426134 |
| 39 | MP0001915_intracranial_hemorrhage | 1.50938226 |
| 40 | MP0001293_anophthalmia | 1.50713912 |
| 41 | MP0003448_altered_tumor_morphology | 1.46741440 |
| 42 | MP0003121_genomic_imprinting | 1.46267471 |
| 43 | MP0002084_abnormal_developmental_patter | 1.46141946 |
| 44 | MP0000733_abnormal_muscle_development | 1.46027241 |
| 45 | MP0003984_embryonic_growth_retardation | 1.45041380 |
| 46 | MP0001529_abnormal_vocalization | 1.43343214 |
| 47 | MP0002233_abnormal_nose_morphology | 1.43303630 |
| 48 | MP0003937_abnormal_limbs/digits/tail_de | 1.43111303 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.41445788 |
| 50 | MP0003787_abnormal_imprinting | 1.38823649 |
| 51 | MP0004270_analgesia | 1.38465420 |
| 52 | MP0002086_abnormal_extraembryonic_tissu | 1.35854993 |
| 53 | MP0004510_myositis | 1.35184087 |
| 54 | MP0003718_maternal_effect | 1.33180945 |
| 55 | MP0003755_abnormal_palate_morphology | 1.32601476 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.32243459 |
| 57 | MP0009785_altered_susceptibility_to | 1.30453585 |
| 58 | MP0004233_abnormal_muscle_weight | 1.30329104 |
| 59 | MP0002085_abnormal_embryonic_tissue | 1.29678384 |
| 60 | MP0004197_abnormal_fetal_growth/weight/ | 1.29452032 |
| 61 | MP0006082_CNS_inflammation | 1.27422404 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.25427497 |
| 63 | MP0004145_abnormal_muscle_electrophysio | 1.20676495 |
| 64 | MP0002080_prenatal_lethality | 1.20488040 |
| 65 | MP0006276_abnormal_autonomic_nervous | 1.20439866 |
| 66 | MP0003122_maternal_imprinting | 1.17967803 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.17464014 |
| 68 | MP0000049_abnormal_middle_ear | 1.16976966 |
| 69 | MP0002106_abnormal_muscle_physiology | 1.14325224 |
| 70 | MP0005330_cardiomyopathy | 1.14048863 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.14043103 |
| 72 | MP0000778_abnormal_nervous_system | 1.12815799 |
| 73 | MP0003385_abnormal_body_wall | 1.11799288 |
| 74 | MP0005621_abnormal_cell_physiology | 1.11078891 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.10506159 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09375376 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.08176270 |
| 78 | MP0003436_decreased_susceptibility_to | 1.08064167 |
| 79 | MP0003091_abnormal_cell_migration | 1.06112933 |
| 80 | MP0002019_abnormal_tumor_incidence | 1.05769508 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.05228411 |
| 82 | MP0001286_abnormal_eye_development | 1.03858592 |
| 83 | MP0005187_abnormal_penis_morphology | 1.01564657 |
| 84 | MP0009250_abnormal_appendicular_skeleto | 1.00053759 |
| 85 | MP0006138_congestive_heart_failure | 0.99320377 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.98977750 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.98977750 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.98139020 |
| 89 | MP0002006_tumorigenesis | 0.97713121 |
| 90 | MP0000313_abnormal_cell_death | 0.97667277 |
| 91 | MP0000750_abnormal_muscle_regeneration | 0.97492828 |
| 92 | MP0000685_abnormal_immune_system | 0.96260674 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.95966899 |
| 94 | MP0004272_abnormal_basement_membrane | 0.95914470 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.95725629 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.95497951 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.95314651 |
| 98 | MP0002697_abnormal_eye_size | 0.95033793 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.94861641 |
| 100 | MP0005499_abnormal_olfactory_system | 0.94861641 |
| 101 | MP0002127_abnormal_cardiovascular_syste | 0.93937986 |
| 102 | MP0002269_muscular_atrophy | 0.92891036 |
| 103 | MP0001188_hyperpigmentation | 0.92755918 |
| 104 | MP0005000_abnormal_immune_tolerance | 0.92659854 |
| 105 | MP0004087_abnormal_muscle_fiber | 0.92625271 |
| 106 | MP0010368_abnormal_lymphatic_system | 0.91328647 |
| 107 | MP0005384_cellular_phenotype | 0.90966734 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.90722501 |
| 109 | MP0000762_abnormal_tongue_morphology | 0.90250757 |
| 110 | MP0002163_abnormal_gland_morphology | 0.89102030 |
| 111 | MP0009672_abnormal_birth_weight | 0.88338762 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.88087547 |
| 113 | MP0003935_abnormal_craniofacial_develop | 0.87562933 |
| 114 | MP0001984_abnormal_olfaction | 0.86385633 |
| 115 | MP0002398_abnormal_bone_marrow | 0.86080277 |
| 116 | MP0003119_abnormal_digestive_system | 0.85862590 |
| 117 | MP0002938_white_spotting | 0.84175391 |
| 118 | MP0005623_abnormal_meninges_morphology | 0.83788429 |
| 119 | MP0005367_renal/urinary_system_phenotyp | 0.83065360 |
| 120 | MP0000516_abnormal_urinary_system | 0.83065360 |
| 121 | MP0003861_abnormal_nervous_system | 0.82473243 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.80861010 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.79713351 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.79457896 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.79205223 |
| 126 | MP0002092_abnormal_eye_morphology | 0.79113739 |
| 127 | MP0005671_abnormal_response_to | 0.79016371 |
| 128 | MP0004085_abnormal_heartbeat | 0.78708184 |
| 129 | MP0009053_abnormal_anal_canal | 0.78344654 |
| 130 | MP0002177_abnormal_outer_ear | 0.78289816 |
| 131 | MP0004858_abnormal_nervous_system | 0.77760789 |
| 132 | MP0006072_abnormal_retinal_apoptosis | 0.77562191 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.77246549 |
| 134 | MP0005385_cardiovascular_system_phenoty | 0.76935395 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.76935395 |
| 136 | MP0002081_perinatal_lethality | 0.76638234 |
| 137 | MP0002102_abnormal_ear_morphology | 0.76555079 |
| 138 | MP0001849_ear_inflammation | 0.76536053 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.75477024 |
| 140 | MP0000749_muscle_degeneration | 0.74926920 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.74756417 |
| 142 | MP0001800_abnormal_humoral_immune | 0.73874507 |
| 143 | MP0005369_muscle_phenotype | 0.71811220 |
| 144 | MP0004036_abnormal_muscle_relaxation | 0.70892996 |
| 145 | MP0000858_altered_metastatic_potential | 0.70001752 |
| 146 | MP0001119_abnormal_female_reproductive | 0.69873700 |
| 147 | MP0002723_abnormal_immune_serum | 0.68582734 |
| 148 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68574063 |
| 149 | MP0008775_abnormal_heart_ventricle | 0.68479711 |
| 150 | MP0000343_altered_response_to | 0.67138324 |
| 151 | MP0000627_abnormal_mammary_gland | 0.66348556 |
| 152 | MP0009333_abnormal_splenocyte_physiolog | 0.62361278 |
| 153 | MP0009703_decreased_birth_body | 0.62246704 |
| 154 | MP0000747_muscle_weakness | 0.61565757 |
| 155 | MP0002925_abnormal_cardiovascular_devel | 0.61430655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.15508813 |
| 2 | Abnormality of the labia minora (HP:0012880) | 3.87082011 |
| 3 | Papillary thyroid carcinoma (HP:0002895) | 3.82562575 |
| 4 | Shoulder girdle muscle weakness (HP:0003547) | 3.80351645 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 3.68331062 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.60691880 |
| 7 | Pelvic girdle muscle weakness (HP:0003749) | 3.59217416 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.57305441 |
| 9 | Cortical dysplasia (HP:0002539) | 3.51669960 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.45750934 |
| 11 | Nemaline bodies (HP:0003798) | 3.42786776 |
| 12 | Agnosia (HP:0010524) | 3.42212828 |
| 13 | Birth length less than 3rd percentile (HP:0003561) | 3.31076183 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 3.30234620 |
| 15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.22105611 |
| 16 | Subaortic stenosis (HP:0001682) | 3.22105611 |
| 17 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.19639311 |
| 18 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.19639311 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 3.12337578 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 3.10916221 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 2.91734740 |
| 22 | Disinhibition (HP:0000734) | 2.87306830 |
| 23 | Facial hemangioma (HP:0000329) | 2.77355462 |
| 24 | Chromsome breakage (HP:0040012) | 2.75257496 |
| 25 | Round ear (HP:0100830) | 2.68325216 |
| 26 | Biliary tract neoplasm (HP:0100574) | 2.68017539 |
| 27 | Neck muscle weakness (HP:0000467) | 2.64187309 |
| 28 | Medulloblastoma (HP:0002885) | 2.61077086 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60886295 |
| 30 | Limb-girdle muscle atrophy (HP:0003797) | 2.49564162 |
| 31 | Cutaneous melanoma (HP:0012056) | 2.47869352 |
| 32 | Thyroid carcinoma (HP:0002890) | 2.47269744 |
| 33 | Patellar aplasia (HP:0006443) | 2.46283054 |
| 34 | Frequent falls (HP:0002359) | 2.40389816 |
| 35 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.40375953 |
| 36 | Spinal rigidity (HP:0003306) | 2.35979534 |
| 37 | Abnormality of the calcaneus (HP:0008364) | 2.34380408 |
| 38 | Inappropriate behavior (HP:0000719) | 2.34082527 |
| 39 | Myoglobinuria (HP:0002913) | 2.31909707 |
| 40 | Ependymoma (HP:0002888) | 2.31482141 |
| 41 | Colon cancer (HP:0003003) | 2.31316059 |
| 42 | Myotonia (HP:0002486) | 2.30449872 |
| 43 | Calcaneovalgus deformity (HP:0001848) | 2.30126485 |
| 44 | Rhabdomyolysis (HP:0003201) | 2.30101068 |
| 45 | Abnormality of the astrocytes (HP:0100707) | 2.24957603 |
| 46 | Astrocytoma (HP:0009592) | 2.24957603 |
| 47 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.23787044 |
| 48 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.20166434 |
| 49 | Apathy (HP:0000741) | 2.19196086 |
| 50 | Bladder neoplasm (HP:0009725) | 2.17890486 |
| 51 | Bladder carcinoma (HP:0002862) | 2.17890486 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.13580884 |
| 53 | Muscle fiber splitting (HP:0003555) | 2.12383594 |
| 54 | Muscle stiffness (HP:0003552) | 2.11748732 |
| 55 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.11611473 |
| 56 | Gastrointestinal carcinoma (HP:0002672) | 2.11611473 |
| 57 | Increased density of long bones (HP:0006392) | 2.09645719 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.04794954 |
| 59 | Wrist flexion contracture (HP:0001239) | 2.03145840 |
| 60 | Deformed tarsal bones (HP:0008119) | 2.02278791 |
| 61 | Cleft eyelid (HP:0000625) | 2.01755738 |
| 62 | Acute myeloid leukemia (HP:0004808) | 2.01739710 |
| 63 | Uterine leiomyosarcoma (HP:0002891) | 2.01496275 |
| 64 | Leiomyosarcoma (HP:0100243) | 2.01496275 |
| 65 | Absent eyebrow (HP:0002223) | 2.01293946 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00500489 |
| 67 | Neoplasm of the small intestine (HP:0100833) | 2.00480341 |
| 68 | Uterine neoplasm (HP:0010784) | 2.00290247 |
| 69 | Hyporeflexia of lower limbs (HP:0002600) | 1.99850179 |
| 70 | Pheochromocytoma (HP:0002666) | 1.97146746 |
| 71 | Degeneration of anterior horn cells (HP:0002398) | 1.96746004 |
| 72 | Abnormality of the anterior horn cell (HP:0006802) | 1.96746004 |
| 73 | Diminished motivation (HP:0000745) | 1.93664786 |
| 74 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.93268516 |
| 75 | Volvulus (HP:0002580) | 1.92317844 |
| 76 | Cafe-au-lait spot (HP:0000957) | 1.91630105 |
| 77 | Rhabdomyosarcoma (HP:0002859) | 1.90542310 |
| 78 | Bundle branch block (HP:0011710) | 1.89433531 |
| 79 | Long clavicles (HP:0000890) | 1.87803887 |
| 80 | Rimmed vacuoles (HP:0003805) | 1.87350943 |
| 81 | Short 4th metacarpal (HP:0010044) | 1.87053811 |
| 82 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.87053811 |
| 83 | Sandal gap (HP:0001852) | 1.87022808 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 1.86675522 |
| 85 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.86570085 |
| 86 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.86535145 |
| 87 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.86484511 |
| 88 | Proximal amyotrophy (HP:0007126) | 1.85055807 |
| 89 | Difficulty running (HP:0009046) | 1.83885300 |
| 90 | Abnormality of the metopic suture (HP:0005556) | 1.83870182 |
| 91 | Abnormal finger flexion creases (HP:0006143) | 1.83858079 |
| 92 | Neoplasm of the oral cavity (HP:0100649) | 1.83685935 |
| 93 | Abnormal lung lobation (HP:0002101) | 1.82307687 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 1.81824035 |
| 95 | Abnormality of chromosome segregation (HP:0002916) | 1.81715372 |
| 96 | Neuroendocrine neoplasm (HP:0100634) | 1.81576804 |
| 97 | Termporal pattern (HP:0011008) | 1.80624790 |
| 98 | Insidious onset (HP:0003587) | 1.80624790 |
| 99 | Slender build (HP:0001533) | 1.79618241 |
| 100 | Ectopic kidney (HP:0000086) | 1.78820006 |
| 101 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78484813 |
| 102 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.75517602 |
| 103 | Absent phalangeal crease (HP:0006109) | 1.75353645 |
| 104 | Microglossia (HP:0000171) | 1.74694500 |
| 105 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.73823413 |
| 106 | Neoplasm of the rectum (HP:0100743) | 1.70487599 |
| 107 | Myopathic facies (HP:0002058) | 1.69593368 |
| 108 | Subacute progressive viral hepatitis (HP:0006572) | 1.69399675 |
| 109 | Amaurosis fugax (HP:0100576) | 1.69199099 |
| 110 | Scapular winging (HP:0003691) | 1.68767039 |
| 111 | Supernumerary spleens (HP:0009799) | 1.68722050 |
| 112 | Distal lower limb muscle weakness (HP:0009053) | 1.68496369 |
| 113 | Type 1 muscle fiber predominance (HP:0003803) | 1.67755537 |
| 114 | Limb dystonia (HP:0002451) | 1.67733241 |
| 115 | Capillary hemangiomas (HP:0005306) | 1.67293720 |
| 116 | Sudden death (HP:0001699) | 1.67239385 |
| 117 | Cystic hygroma (HP:0000476) | 1.67168973 |
| 118 | Increased serum pyruvate (HP:0003542) | 1.66613091 |
| 119 | Hip contracture (HP:0003273) | 1.66345322 |
| 120 | Porencephaly (HP:0002132) | 1.66176509 |
| 121 | Prominent metopic ridge (HP:0005487) | 1.65981497 |
| 122 | Poor head control (HP:0002421) | 1.65049724 |
| 123 | Intellectual disability, profound (HP:0002187) | 1.64568752 |
| 124 | Malignant hyperthermia (HP:0002047) | 1.64409023 |
| 125 | Fused cervical vertebrae (HP:0002949) | 1.64015611 |
| 126 | Areflexia of lower limbs (HP:0002522) | 1.63853807 |
| 127 | Amyotrophic lateral sclerosis (HP:0007354) | 1.62527846 |
| 128 | Abnormality of the fingertips (HP:0001211) | 1.61395699 |
| 129 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.61379933 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.61217431 |
| 131 | Prostate neoplasm (HP:0100787) | 1.61025467 |
| 132 | Broad thumb (HP:0011304) | 1.60782590 |
| 133 | Cutis marmorata (HP:0000965) | 1.58758741 |
| 134 | Hypoalphalipoproteinemia (HP:0003233) | 1.58528863 |
| 135 | Personality changes (HP:0000751) | 1.58366967 |
| 136 | Eczematoid dermatitis (HP:0000976) | 1.58088667 |
| 137 | Glioma (HP:0009733) | 1.57923642 |
| 138 | Increased connective tissue (HP:0009025) | 1.57244943 |
| 139 | Limb-girdle muscle weakness (HP:0003325) | 1.57061533 |
| 140 | Absent radius (HP:0003974) | 1.56809743 |
| 141 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.56625263 |
| 142 | Retrobulbar optic neuritis (HP:0100654) | 1.56412757 |
| 143 | Optic neuritis (HP:0100653) | 1.56412757 |
| 144 | Myelodysplasia (HP:0002863) | 1.56302017 |
| 145 | Intestinal atresia (HP:0011100) | 1.53950857 |
| 146 | Bifid tongue (HP:0010297) | 1.53458624 |
| 147 | Embryonal renal neoplasm (HP:0011794) | 1.53004360 |
| 148 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.52175171 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.50842269 |
| 150 | Delayed gross motor development (HP:0002194) | 1.47536854 |
| 151 | Multiple enchondromatosis (HP:0005701) | 1.46428716 |
| 152 | Hepatoblastoma (HP:0002884) | 1.46221737 |
| 153 | Muscular dystrophy (HP:0003560) | 1.43152127 |
| 154 | Optic nerve hypoplasia (HP:0000609) | 1.42788680 |
| 155 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.41893148 |
| 156 | EMG: neuropathic changes (HP:0003445) | 1.41552864 |
| 157 | Dilated cardiomyopathy (HP:0001644) | 1.40025624 |
| 158 | Neoplasm of the adrenal gland (HP:0100631) | 1.38891926 |
| 159 | Drooling (HP:0002307) | 1.37543193 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.36705281 |
| 161 | Limited hip movement (HP:0008800) | 1.36198052 |
| 162 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.35755867 |
| 163 | Webbed neck (HP:0000465) | 1.34985772 |
| 164 | Hyperalaninemia (HP:0003348) | 1.33311613 |
| 165 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.33311613 |
| 166 | Abnormality of alanine metabolism (HP:0010916) | 1.33311613 |
| 167 | Absent septum pellucidum (HP:0001331) | 1.31701337 |
| 168 | Neoplasm of the colon (HP:0100273) | 1.30971424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDC7 | 3.88678894 |
| 2 | NEK1 | 3.20125760 |
| 3 | KSR2 | 2.76895528 |
| 4 | TRIM28 | 2.72922935 |
| 5 | MAP3K9 | 2.62459361 |
| 6 | LATS2 | 2.51967630 |
| 7 | LATS1 | 2.51572872 |
| 8 | SCYL2 | 2.47406219 |
| 9 | PLK4 | 2.28486361 |
| 10 | PLK2 | 2.27121840 |
| 11 | PHKG1 | 2.11917550 |
| 12 | PHKG2 | 2.11917550 |
| 13 | PLK3 | 2.02644828 |
| 14 | PBK | 1.94950032 |
| 15 | ERBB3 | 1.90702960 |
| 16 | MAP3K13 | 1.85213090 |
| 17 | CDK12 | 1.84347882 |
| 18 | TTK | 1.84054840 |
| 19 | MST4 | 1.82475104 |
| 20 | PNCK | 1.79033169 |
| 21 | KSR1 | 1.77010168 |
| 22 | EIF2AK1 | 1.76505421 |
| 23 | ERBB4 | 1.75977304 |
| 24 | MKNK2 | 1.67664171 |
| 25 | NEK2 | 1.67177892 |
| 26 | TNIK | 1.64329390 |
| 27 | WNK3 | 1.62718918 |
| 28 | MAP3K14 | 1.62077511 |
| 29 | TTN | 1.60167734 |
| 30 | EEF2K | 1.56556630 |
| 31 | NEK9 | 1.55264602 |
| 32 | CASK | 1.47036917 |
| 33 | STK3 | 1.45423046 |
| 34 | JAK3 | 1.42048198 |
| 35 | TSSK6 | 1.41474493 |
| 36 | RAF1 | 1.40936571 |
| 37 | CCNB1 | 1.39496404 |
| 38 | ACVR1B | 1.35490661 |
| 39 | RPS6KA4 | 1.34824944 |
| 40 | PLK1 | 1.33912322 |
| 41 | STK38L | 1.30045976 |
| 42 | BRAF | 1.26410178 |
| 43 | SRPK1 | 1.25395114 |
| 44 | LIMK1 | 1.24506218 |
| 45 | WEE1 | 1.23363481 |
| 46 | MAP3K5 | 1.21015902 |
| 47 | MAP3K8 | 1.20902397 |
| 48 | TAF1 | 1.17738131 |
| 49 | PDK2 | 1.16233625 |
| 50 | MAP3K12 | 1.16126239 |
| 51 | PINK1 | 1.14212019 |
| 52 | ALK | 1.13992411 |
| 53 | CHEK1 | 1.13345704 |
| 54 | MAP3K4 | 1.12703810 |
| 55 | ATR | 1.10413641 |
| 56 | TYK2 | 1.06743471 |
| 57 | MAP3K6 | 1.02330962 |
| 58 | ARAF | 0.95920026 |
| 59 | CHEK2 | 0.95632210 |
| 60 | PKN2 | 0.95459315 |
| 61 | CDK6 | 0.94312879 |
| 62 | BRSK2 | 0.93229070 |
| 63 | MELK | 0.93111427 |
| 64 | ATM | 0.90960834 |
| 65 | MARK1 | 0.89661335 |
| 66 | CSNK1G1 | 0.89530356 |
| 67 | STK10 | 0.89499836 |
| 68 | NUAK1 | 0.88543919 |
| 69 | TESK1 | 0.83992732 |
| 70 | PAK3 | 0.83234023 |
| 71 | BCR | 0.83091203 |
| 72 | PASK | 0.82488415 |
| 73 | OBSCN | 0.82411850 |
| 74 | AURKB | 0.82249708 |
| 75 | CSNK1G2 | 0.80480068 |
| 76 | PAK6 | 0.79109809 |
| 77 | BMPR1B | 0.78511089 |
| 78 | CSNK1G3 | 0.76797840 |
| 79 | MKNK1 | 0.76115967 |
| 80 | CDK4 | 0.73580908 |
| 81 | PIK3CG | 0.73337694 |
| 82 | FRK | 0.73155318 |
| 83 | EIF2AK3 | 0.72103634 |
| 84 | CHUK | 0.71875594 |
| 85 | BRD4 | 0.71547290 |
| 86 | STK39 | 0.70781970 |
| 87 | CDK2 | 0.69897378 |
| 88 | RET | 0.69601966 |
| 89 | MAP2K7 | 0.68202205 |
| 90 | STK4 | 0.67220918 |
| 91 | MAP2K4 | 0.66722755 |
| 92 | TIE1 | 0.66549107 |
| 93 | CSNK1A1L | 0.65143994 |
| 94 | BRSK1 | 0.63830148 |
| 95 | STK24 | 0.62295085 |
| 96 | BMX | 0.61341747 |
| 97 | ABL2 | 0.60977699 |
| 98 | CDK1 | 0.60872612 |
| 99 | DYRK2 | 0.60395655 |
| 100 | CDK19 | 0.60279765 |
| 101 | STK16 | 0.60138089 |
| 102 | FGFR1 | 0.60088975 |
| 103 | TBK1 | 0.59801314 |
| 104 | RIPK4 | 0.58210177 |
| 105 | MINK1 | 0.57398026 |
| 106 | DYRK3 | 0.57319191 |
| 107 | BUB1 | 0.56851013 |
| 108 | MAP3K10 | 0.56155407 |
| 109 | MOS | 0.55670248 |
| 110 | EPHB2 | 0.53918635 |
| 111 | AKT2 | 0.53894192 |
| 112 | CSNK1E | 0.53842736 |
| 113 | RPS6KB2 | 0.53495356 |
| 114 | PRKD3 | 0.50153424 |
| 115 | MUSK | 0.49875053 |
| 116 | JAK2 | 0.49786017 |
| 117 | DAPK1 | 0.49587526 |
| 118 | CDK11A | 0.49557036 |
| 119 | TAOK1 | 0.46784815 |
| 120 | FGFR3 | 0.46553005 |
| 121 | CDK7 | 0.45985725 |
| 122 | CAMK2A | 0.45675284 |
| 123 | TRPM7 | 0.45508843 |
| 124 | TYRO3 | 0.45149042 |
| 125 | MAPK10 | 0.44824654 |
| 126 | CLK1 | 0.44764690 |
| 127 | CAMK2D | 0.44454087 |
| 128 | ROCK1 | 0.44297848 |
| 129 | CDK14 | 0.44147272 |
| 130 | AURKA | 0.43356272 |
| 131 | CSNK1D | 0.42641443 |
| 132 | VRK2 | 0.42350329 |
| 133 | SIK3 | 0.42305862 |
| 134 | MAPK13 | 0.42266478 |
| 135 | JAK1 | 0.41209788 |
| 136 | VRK1 | 0.40018005 |
| 137 | DMPK | 0.38878231 |
| 138 | TGFBR1 | 0.38397212 |
| 139 | EIF2AK2 | 0.38305684 |
| 140 | PDGFRA | 0.38245198 |
| 141 | CDK18 | 0.37429420 |
| 142 | OXSR1 | 0.37159405 |
| 143 | PIM1 | 0.35778255 |
| 144 | IKBKB | 0.34993369 |
| 145 | ROCK2 | 0.34926942 |
| 146 | CAMK2G | 0.34188280 |
| 147 | CDK15 | 0.34090453 |
| 148 | FGR | 0.32452863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.79778017 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.46079319 |
| 3 | Cell cycle_Homo sapiens_hsa04110 | 2.43744513 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.37559734 |
| 5 | RNA transport_Homo sapiens_hsa03013 | 2.15064741 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.10534714 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.01650618 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.01123962 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93045164 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91816866 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.84514904 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.79657241 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.79593903 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.79403277 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.70949694 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.69345486 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63360958 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.61379458 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58509135 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57186654 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.56345622 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56236165 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53704824 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.51972799 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51654594 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.47508124 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47174415 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47129407 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46380941 |
| 30 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.44256597 |
| 31 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.43975705 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.43612888 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.43418329 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.40053968 |
| 35 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.39954119 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34156537 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33038810 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.31895542 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.30665423 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.30461760 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29977172 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.29907319 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.29904122 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.29746179 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29245807 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26701218 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.25591915 |
| 48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.21102172 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 1.20566139 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 1.20328086 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.20308586 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19275132 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19046898 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 1.16235953 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16016981 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14958314 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14123908 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12912669 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11941304 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10377724 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.09796333 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 1.09306166 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09149411 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 1.07716727 |
| 65 | Homologous recombination_Homo sapiens_hsa03440 | 1.06871649 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 1.05221706 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 1.03877073 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03827480 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02394938 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02089748 |
| 71 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.01940318 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98387265 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.97732915 |
| 74 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97232524 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96784689 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96387986 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95123890 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94603095 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.92427018 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92239043 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.91818556 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89932019 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89862799 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89044727 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88940753 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88761562 |
| 87 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87614205 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.87075487 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86978080 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.85929540 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.85439463 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84617960 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84103421 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84074290 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84010036 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83206947 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81550866 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81485035 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81391547 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80957061 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79251589 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.78846975 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77530869 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.76999784 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75276993 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73152635 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72677592 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.70347961 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.68995028 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68469860 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67773970 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67756758 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66799687 |
| 114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66428650 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65617421 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64834162 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64776268 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64507098 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.64451266 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64352254 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63983401 |
| 122 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63691956 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63488586 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63175014 |
| 125 | Phagosome_Homo sapiens_hsa04145 | 0.63027733 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | 0.62807839 |
| 127 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62555956 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61907753 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61562848 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61440188 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.61272638 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60472472 |
| 133 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59797746 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59666061 |
| 135 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59401328 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57778373 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57464186 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55461244 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54390551 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54015133 |
| 141 | Long-term potentiation_Homo sapiens_hsa04720 | 0.53592384 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53437630 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.53216096 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.53178300 |
| 145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50379176 |
| 146 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50365444 |
| 147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50251634 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.49783271 |
| 149 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48398025 |
| 150 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48124248 |
| 151 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47968021 |
| 152 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47632954 |
| 153 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47576460 |
| 154 | Focal adhesion_Homo sapiens_hsa04510 | 0.46266082 |
| 155 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45663692 |
| 156 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44446838 |
| 157 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43905317 |
| 158 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.40979690 |
| 159 | Long-term depression_Homo sapiens_hsa04730 | 0.40617849 |
| 160 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39089531 |
| 161 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38772202 |
| 162 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38293368 |
| 163 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37549123 |
| 164 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37223670 |
| 165 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36572361 |
| 166 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36529395 |

